| MicroRNA therapeutics: towards a new era for the management of cancer and other diseases R Rupaimoole, FJ Slack Nature reviews Drug discovery 16 (3), 203-222, 2017 | 4653 | 2017 |
| Paraneoplastic thrombocytosis in ovarian cancer RL Stone, AM Nick, IA McNeish, F Balkwill, HD Han, J Bottsford-Miller, ... New England Journal of Medicine 366 (7), 610-618, 2012 | 907 | 2012 |
| miRNA deregulation in cancer cells and the tumor microenvironment R Rupaimoole, GA Calin, G Lopez-Berestein, AK Sood Cancer discovery 6 (3), 235-246, 2016 | 692 | 2016 |
| Integrated analyses identify a master microRNA regulatory network for the mesenchymal subtype in serous ovarian cancer D Yang, Y Sun, L Hu, H Zheng, P Ji, CV Pecot, Y Zhao, S Reynolds, ... Cancer cell 23 (2), 186-199, 2013 | 453 | 2013 |
| Tumour angiogenesis regulation by the miR-200 family CV Pecot, R Rupaimoole, D Yang, R Akbani, C Ivan, C Lu, S Wu, HD Han, ... Nature communications 4 (1), 2427, 2013 | 444 | 2013 |
| Metabolic shifts toward glutamine regulate tumor growth, invasion and bioenergetics in ovarian cancer L Yang, T Moss, LS Mangala, J Marini, H Zhao, S Wahlig, G Armaiz‐Pena, ... Molecular systems biology 10 (5), 728, 2014 | 372 | 2014 |
| Hematogenous metastasis of ovarian cancer: rethinking mode of spread S Pradeep, SW Kim, SY Wu, M Nishimura, P Chaluvally-Raghavan, ... Cancer cell 26 (1), 77-91, 2014 | 356 | 2014 |
| Hypoxia promotes stem cell phenotypes and poor prognosis through epigenetic regulation of DICER T Van Den Beucken, E Koch, K Chu, R Rupaimoole, P Prickaerts, ... Nature communications 5 (1), 5203, 2014 | 242 | 2014 |
| Platelets reduce anoikis and promote metastasis by activating YAP1 signaling M Haemmerle, ML Taylor, T Gutschner, S Pradeep, MS Cho, J Sheng, ... Nature communications 8 (1), 310, 2017 | 234 | 2017 |
| Autocrine effects of tumor-derived complement MS Cho, HG Vasquez, R Rupaimoole, S Pradeep, S Wu, B Zand, HD Han, ... Cell reports 6 (6), 1085-1095, 2014 | 225 | 2014 |
| Role of focal adhesion kinase in regulating YB–1–mediated paclitaxel resistance in ovarian cancer Y Kang, W Hu, C Ivan, HJ Dalton, T Miyake, CV Pecot, B Zand, T Liu, ... Journal of the National Cancer Institute 105 (19), 1485-1495, 2013 | 203 | 2013 |
| Hypoxia-mediated downregulation of miRNA biogenesis promotes tumour progression R Rupaimoole, SY Wu, S Pradeep, C Ivan, CV Pecot, KM Gharpure, ... Nature communications 5 (1), 5202, 2014 | 195 | 2014 |
| FABP4 as a key determinant of metastatic potential of ovarian cancer KM Gharpure, S Pradeep, M Sans, R Rupaimoole, C Ivan, SY Wu, ... Nature communications 9 (1), 1-14, 2018 | 187 | 2018 |
| Combining anti-miR-155 with chemotherapy for the treatment of lung cancers K Van Roosbroeck, F Fanini, T Setoyama, C Ivan, C Rodriguez-Aguayo, ... Clinical Cancer Research 23 (11), 2891-2904, 2017 | 158 | 2017 |
| Yes‐associated protein 1 and transcriptional coactivator with PDZ‐binding motif activate the mammalian target of rapamycin complex 1 pathway by regulating amino acid … YY Park, BH Sohn, RL Johnson, MH Kang, SB Kim, JJ Shim, LS Mangala, ... Hepatology 63 (1), 159-172, 2016 | 143 | 2016 |
| A miR-192-EGR1-HOXB9 regulatory network controls the angiogenic switch in cancer SY Wu, R Rupaimoole, F Shen, S Pradeep, CV Pecot, C Ivan, ... Nature communications 7 (1), 11169, 2016 | 140 | 2016 |
| 2′-OMe-phosphorodithioate-modified siRNAs show increased loading into the RISC complex and enhanced anti-tumour activity SY Wu, X Yang, KM Gharpure, H Hatakeyama, M Egli, MH McGuire, ... Nature communications 5 (1), 3459, 2014 | 137 | 2014 |
| Augmentation of response to chemotherapy by microRNA-506 through regulation of RAD51 in serous ovarian cancers G Liu, D Yang, R Rupaimoole, CV Pecot, Y Sun, LS Mangala, X Li, P Ji, ... JNCI: Journal of the National Cancer Institute 107 (7), djv108, 2015 | 136 | 2015 |
| FAK regulates platelet extravasation and tumor growth after antiangiogenic therapy withdrawal M Haemmerle, J Bottsford-Miller, S Pradeep, ML Taylor, HJ Choi, ... The Journal of clinical investigation 126 (5), 1885-1896, 2016 | 131 | 2016 |
| MicroRNA therapeutics: principles, expectations, and challenges R Rupaimoole, HD Han, G Lopez-Berestein, AK Sood Chinese journal of cancer 30 (6), 368, 2011 | 126 | 2011 |